How do you actually measure the return on your medical device marketing? If you're pulling data from six different dashboards, copying numbers into spreadsheets, and still can't connect a single campaign to actual revenue, you're not alone.
Measuring medical device marketing ROI is one of the most common challenges we hear about from the companies we work with. Long sales cycles, multiple decision makers, a mix of online and offline touchpoints, and a fragmented set of marketing platforms all make it incredibly difficult to answer what should be a simple question: is our marketing generating revenue?
In this article, we'll walk through the different approaches to measuring marketing ROI in medical devices. We'll start with the individual platforms most companies are already using, explain why they only tell part of the story, and then look at end-to-end CRM platforms that can connect marketing activity to closed deals and actual revenue.
A note on transparency: Podymos is a HubSpot partner agency. We use HubSpot ourselves and we help medical device companies set it up. We'll cover HubSpot in this article alongside Salesforce, Microsoft Dynamics 365, and AcuityMD, and we'll be honest about the strengths and limitations of each. Where our experience with HubSpot informs our perspective, we'll say so.
This article covers:
Medical device marketing doesn't follow the same patterns as most B2B marketing, and that's what makes measurement so hard. Several factors combine to create a measurement challenge that's significantly more complex than what you'd face in, say, SaaS or consumer products.
First, there's the length of the sales cycle. A typical medical device sale, particularly for capital equipment, can take anywhere from six to 18 months from first touch to signed purchase order. That means the marketing activity that started the conversation may have happened over a year before the deal closes. Connecting those dots requires a system that tracks the entire journey, not just the last interaction.
Second, there are multiple decision makers involved. A single purchase might require buy-in from surgeons, procurement teams, biomedical engineers, value analysis committees, and hospital administrators. Each of these stakeholders may interact with your marketing through different channels at different times. The surgeon might watch a KOL webinar. The procurement lead might download a cost comparison PDF. The administrator might read a case study on your website. All of these touchpoints matter, but they're spread across different people and different platforms.
Third, many of the most important interactions in medical device sales happen offline. Congresses, in-service evaluations, site visits, dinner meetings with KOLs, and one-to-one conversations with your sales team are all critical parts of the buying journey. These touchpoints are often invisible to digital analytics tools.
Finally, medical device marketing is predominantly business to business and typically involves prescription-only products. You're not running an e-commerce store where someone clicks an ad and buys. There's no neat, linear path from click to purchase. The journey is messy, and measuring it requires accepting that messiness while building systems that capture as much of it as possible.
Before we talk about how to measure it, it's worth being clear about what marketing ROI actually is, because there's a lot of confusion between activity metrics and genuine return on investment.
Marketing ROI, in its simplest form, is the revenue generated from your marketing activities relative to the cost of those activities. If you spent £50,000 on marketing over a quarter and it contributed to £500,000 in closed deals, that's a 10x return. Simple in theory. Extremely difficult in practice.
The problem is that most of the metrics you'll see in your marketing dashboards aren't ROI metrics at all. They're activity metrics or engagement metrics. Website traffic, social media impressions, email open rates, click-through rates, follower counts, and even leads generated are all useful indicators of marketing performance, but none of them tell you whether your marketing is actually making money.
We see a lot of medical device companies reporting on these metrics and calling it ROI measurement. It isn't. These are leading indicators, and they have their place, but they're not the same as connecting a marketing activity to revenue. The distinction matters because it affects how you make decisions. If you're optimising for clicks or leads without knowing which of those leads actually turned into revenue, you could be scaling the wrong campaigns and cutting the ones that are quietly driving your biggest deals.
True marketing ROI measurement requires you to track the full journey: from the first time someone interacts with your brand, through every subsequent touchpoint, all the way to a closed deal with a revenue value attached. That's what we'll be discussing for the rest of this article.
Most medical device companies start their measurement journey with the analytics built into each marketing platform they use. This is a natural and sensible starting point. Each platform gives you data about how your activity on that specific channel is performing. The challenge is that each one only shows you its own piece of the puzzle.
Let's walk through the most common platforms and what each one can and can't tell you.
These three tools work together and are foundational to any digital marketing measurement setup. Google Analytics 4 (GA4) tracks what happens on your website: who's visiting, where they came from, what pages they're looking at, and what actions they're taking. Google Search Console tells you how your website is performing in organic search: which queries are driving impressions and clicks, which pages are ranking, and where your technical SEO health stands. Google Tag Manager (GTM) is the implementation layer that ties it all together.
GTM is worth explaining because it's often overlooked. It's a free tool that lets you deploy and manage all your tracking tags, including your GA4 tracking code, conversion pixels, and custom event triggers, without needing to edit your website's code directly every time you want to track something new. Want to track when someone clicks a "book a demo" button, downloads a PDF, watches a video, or scrolls to the bottom of a case study page? GTM lets you set all of that up through its interface and push it live without involving a developer. For medical device companies with limited technical resource, this is a significant advantage. Without GTM, many of the actions that matter most on your website simply won't be captured in GA4, which means your conversion data will be incomplete before you've even started trying to measure ROI.
Together, these three tools give you a solid picture of your website's performance. GA4 and Search Console show you which channels are driving the most traffic, which pages are generating the most engagement, and which organic search terms are bringing people to your site. GTM ensures that the specific actions you care about (form submissions, content downloads, demo requests, video plays) are actually being recorded as events and conversions in GA4. If you're running any digital marketing at all, you should have all three set up and configured properly.
Where they fall short is in connecting website activity to revenue. GA4 can track conversions, and you can assign estimated values to those conversions, but it can't tell you whether that lead eventually became a customer or how much revenue they generated. It also struggles with the long, multi-session journeys that are typical in medical device buying. A surgeon who visits your site six times over four months before their hospital raises a purchase order is difficult for GA4 to track as a single journey.
UTM codes are the glue that connects your campaign activity to your analytics. They're tags you add to the end of URLs so that when someone clicks a link in an email, a social post, or a paid ad, your analytics platform knows exactly where they came from, which campaign sent them, and what content they clicked on.
For example, a link in a LinkedIn post promoting a webinar might include UTM parameters for source (LinkedIn), medium (social), campaign (webinar-launch-2026), and content (post-version-A). When that person lands on your website, GA4 captures all of those details, giving you granular data about which specific campaigns and channels are driving traffic and conversions.
UTM codes are essential and free. If you're not using them consistently, you're flying blind on a significant portion of your digital activity. However, like GA4 itself, they only track up to the point of a website conversion. They can't follow that person through your sales pipeline to a closed deal unless your UTM data flows into a CRM, which is where end-to-end platforms come in (and we'll cover that shortly).
For most medical device companies, LinkedIn is the primary social advertising platform, and its Campaign Manager provides detailed analytics on paid campaign performance. You can see impressions, clicks, click-through rates, cost per click, leads generated through LinkedIn Lead Gen Forms, and demographic breakdowns of who's engaging with your ads (by job title, seniority, company, industry, and more).
This demographic data is particularly valuable in medical devices because it tells you whether you're actually reaching the right people. If your ads are getting clicks but the audience is mostly students or people outside your target specialties, that's important to know.
The limitation is the same as every other platform: LinkedIn can tell you how your LinkedIn campaigns performed in isolation, but it can't tell you what happened after someone clicked through to your website and eventually spoke to your sales team. LinkedIn also has its own attribution window (typically 30 days for click-through and seven days for view-through), which may not align with the reality of an 18-month medical device sales cycle.
If you're running awareness campaigns on Facebook or Instagram, Meta Ads Manager provides performance data for those platforms. You'll see reach, impressions, frequency, clicks, cost per result, and engagement metrics. For medical device companies, Meta's platforms tend to be more useful for broad awareness and employer branding than for direct lead generation, though there are exceptions depending on your audience.
Meta's analytics are self-contained. They tell you how your Meta campaigns are performing within the Meta ecosystem, but they have limited visibility into what happens once someone leaves that ecosystem. Meta also applies its own attribution models, which can sometimes paint a more flattering picture of performance than what you'd see from an independent analytics platform.
Google Ads provides detailed reporting on your paid search and display campaigns, including cost per click, conversion rates, and quality scores. For medical device companies running search ads targeting specific clinical terms or product categories, this data helps you understand which keywords and ad copy are driving the most qualified traffic to your website.
Google Ads can also import offline conversions if you set it up correctly, which is useful if you want to feed deal data back into the platform to help it optimise for the types of clicks that actually lead to revenue. However, this requires a CRM integration, which brings us back to the central challenge: without a system connecting ad clicks to closed deals, Google Ads can only report on its own slice of the picture.
Whether you're using Mailchimp, Campaign Monitor, ActiveCampaign, or another dedicated email platform, you'll have access to open rates, click rates, bounce rates, and unsubscribe rates for each send. These metrics help you understand how your email content is performing and whether your audience is engaged.
Most email platforms also provide some level of automation analytics, showing you how people move through sequences and which emails drive the most clicks. What they can't typically show you is what happened after that click. Did the person who clicked your case study link eventually become a customer? How much revenue did they generate? If your email platform isn't connected to your CRM, these questions go unanswered.
Tools like Hootsuite, Buffer, or Sprout Social aggregate your organic social media performance across multiple platforms. They'll show you engagement rates, follower growth, best-performing content, and posting frequency. For teams managing social media across LinkedIn, X (formerly Twitter), and other platforms, they're useful for understanding what content resonates.
However, organic social media metrics are some of the furthest removed from revenue. They're useful for understanding brand awareness and audience engagement, but connecting a LinkedIn post to a closed deal six months later is effectively impossible without a system that tracks the entire journey.
If you're using even half of the platforms listed above, you're already dealing with the fundamental problem: your marketing data lives in silos. Each platform has its own dashboard, its own metrics, its own attribution model, and its own definition of success. None of them talk to each other by default.
The most common workaround we see is the monthly spreadsheet. Someone on the marketing team spends hours pulling data from each platform, copying it into a master spreadsheet, and trying to create a unified view of marketing performance. We've seen companies with elaborate spreadsheets that combine data from GA4, LinkedIn, Google Ads, their email platform, and their CRM into one place.
This approach is better than looking at each platform in isolation, but it has serious limitations. It's time-consuming and manual, which means it's prone to errors and it only happens periodically (usually monthly). It typically captures top-level metrics from each platform rather than contact-level data, so you still can't trace a specific person's journey across platforms. And it creates a reporting lag: by the time you've compiled last month's data, you're already making decisions based on information that's weeks old.
Perhaps most critically, spreadsheet collation still doesn't solve the revenue attribution problem. You might be able to see that LinkedIn generated 50 leads and Google Ads generated 30 leads last month, but you still don't know which of those 80 leads turned into customers, how much revenue they generated, or which touchpoints along the way were most influential in closing the deal.
This is the core issue: there's a disconnect between the metrics your marketing platforms report and the outcomes your business actually cares about. Your marketing team can tell you about traffic, engagement, and leads. Your sales team can tell you about pipeline and closed deals. But without a system that connects the two, there's a gap in the middle where attribution disappears.
This gap has real consequences. Marketing teams struggle to justify their budgets because they can't prove their contribution to revenue. Sales teams don't trust marketing-generated leads because they can't see the quality or context behind them. And leadership can't make informed decisions about where to invest because no one can reliably connect spend to return.
In medical devices, where sales cycles are long and deal values are high, this gap is particularly costly. A single misallocated campaign budget could mean tens or hundreds of thousands of pounds in lost revenue over the course of a year.
The most effective way to close the gap between marketing activity and revenue is with a CRM (customer relationship management) platform that tracks the entire journey, from first touch to closed deal. When set up correctly, a CRM becomes the single source of truth for both marketing and sales data, allowing you to see exactly which campaigns, channels, and content contributed to each deal.
This is called revenue attribution, and it's the gold standard for measuring marketing ROI. Instead of reporting on leads or clicks in isolation, you're reporting on revenue and connecting it back to every marketing touchpoint that played a role.
There are several CRM platforms capable of doing this, each with different strengths. Let's look at four that are particularly relevant for medical device companies.
HubSpot is an all-in-one platform that combines CRM, marketing automation, sales tools, and analytics in a single system. This is the platform we use and recommend at Podymos (we're a HubSpot partner, as we mentioned at the top of this article), so we'll be transparent about what it does well and where it has limitations.
HubSpot's biggest strength for ROI measurement is that your marketing tools and your CRM live in the same place. When someone clicks a link in an email you sent through HubSpot, fills in a form on a landing page built in HubSpot, and is later tracked as a contact through your sales pipeline in HubSpot, the entire journey is recorded in one system. There's no need to export data between platforms or build integrations to connect the dots. UTM data from your campaigns flows directly into contact records, so you can see exactly which campaign brought someone into your pipeline.
At the Marketing Hub Enterprise level, HubSpot offers multi-touch revenue attribution reporting. This allows you to see which marketing campaigns contributed to closed deals and attribute revenue credit across multiple touchpoints using models like first touch, last touch, linear, U-shaped, W-shaped, and full path. You can report on contact creation, deal creation, and revenue attribution separately, giving you a full-funnel view from awareness through to closed revenue.
The main limitations are worth noting. Multi-touch revenue attribution requires Marketing Hub Enterprise, which is a significant investment. HubSpot's native attribution models are powerful for tracking post-lead engagement, but they have less visibility into anonymous pre-lead activity (ad impressions, dark social, and other touchpoints that happen before someone identifies themselves). For very large enterprises with complex, multi-brand operations, HubSpot may feel less customisable than Salesforce. That said, for small to mid-sized medical device companies, HubSpot's balance of power and usability is hard to beat.
Salesforce is the most widely used CRM in the medical device industry, particularly among larger companies. It's highly customisable and has deep integration capabilities with virtually every marketing tool on the market, from Marketo and Pardot (now Marketing Cloud Account Engagement) to third-party analytics and BI tools like Tableau and Power BI.
For revenue attribution, Salesforce offers several approaches. At the basic level, it uses Primary Campaign Source, a last-touch model that attributes each opportunity to the most recent campaign that influenced the lead. For more sophisticated attribution, Customizable Campaign Influence allows you to associate multiple campaigns with a single opportunity and distribute revenue credit using first-touch, last-touch, or even distribution models. You can view all three simultaneously, giving you different perspectives on which campaigns are driving results.
Salesforce's strength is its depth and flexibility. For large medical device companies with complex sales processes, multiple product lines, and dedicated technical teams, Salesforce can be configured to track virtually anything. It also integrates well with healthcare-specific tools and is commonly used alongside commercial intelligence platforms.
The trade-off is complexity. Salesforce's reporting and dashboards provide basic analytics, but most medical device companies layer a business intelligence tool on top to get the multi-touch attribution and pipeline velocity metrics they need. Setup requires significant technical expertise, and ongoing maintenance often requires a dedicated administrator. It's a powerful platform, but it's not something you can set up over a weekend.
Microsoft Dynamics 365 is often the natural choice for medical device companies that are already embedded in the Microsoft ecosystem. If your organisation is already using Microsoft 365, Teams, Outlook, and SharePoint, Dynamics 365 integrates seamlessly into that environment.
Dynamics 365 Customer Insights (formerly Dynamics 365 Marketing) provides marketing automation, customer journey orchestration, and analytics capabilities. It uses Copilot, Microsoft's AI assistant, to adjust customer journeys in real time based on customer data and engagement behaviour. It also connects transactional, behavioural, and demographic data into unified customer profiles, which is useful for understanding how different stakeholders within an account are engaging with your marketing.
For revenue attribution, Dynamics 365 offers campaign tracking and the ability to connect marketing activities to opportunities and closed deals. It integrates with Power BI for advanced analytics and custom attribution modelling. However, its native attribution capabilities are generally considered less mature than HubSpot's purpose-built multi-touch attribution or Salesforce's customisable campaign influence. If sophisticated revenue attribution is your primary goal, you may need to supplement Dynamics 365 with additional analytics tools.
The main advantage is the Microsoft ecosystem integration. If your sales team lives in Outlook and Teams, Dynamics 365 can feel like a natural extension of their existing workflow rather than a separate system they need to log into. This can help with adoption, which, as we'll discuss shortly, is one of the biggest challenges with CRM implementation.
AcuityMD is a commercial intelligence platform built specifically for the medical device industry, and it takes a fundamentally different approach to the ROI measurement challenge. While HubSpot, Salesforce, and Dynamics 365 are general-purpose CRMs with marketing attribution capabilities, AcuityMD is purpose-built for MedTech commercialisation.
AcuityMD connects external market data (physician procedural volumes, product preferences, sites-of-care affiliations, peer networks, and referral patterns) with your internal sales data to help you identify and prioritise the highest-value opportunities. It's used by more than 300 MedTech companies, including six of the top 10 globally.
For ROI measurement, AcuityMD's value lies in connecting commercial intelligence to sales outcomes. Rather than tracking marketing touchpoints in the traditional sense (email clicks, website visits, ad engagement), it helps you understand which accounts and physicians represent the biggest opportunities and whether your commercial efforts are converting those opportunities into revenue. It can show whether the territories and accounts your marketing is targeting are the right ones, and whether product adoption is growing in the areas you're investing in.
AcuityMD isn't a traditional CRM or marketing automation platform, so it doesn't replace HubSpot or Salesforce for tracking individual marketing campaigns. Instead, it complements them by providing the market intelligence layer that helps you focus your marketing efforts where they'll have the most impact. If you want to learn more about how platforms like AcuityMD fit into the broader commercial intelligence landscape, we've covered this in more detail in our article on MedTech commercial intelligence platforms.
To make this tangible, here's an example of what multi-touch revenue attribution looks like in practice for a medical device company.
Imagine a hospital eventually purchases your surgical device for £250,000. With multi-touch attribution set up in your CRM, you can see the full journey: the head of surgery first found your website through an organic Google search for a clinical term (tracked in GA4 and your CRM via search console data). Two weeks later, they clicked a LinkedIn ad promoting a KOL webinar (tracked via UTM codes flowing into the CRM). They attended the webinar and passed the recording to a colleague. A month later, the procurement lead downloaded a cost comparison PDF from your website after clicking a link in a nurture email. Three months after that, both attended your congress stand. Your sales team logged the meeting in the CRM. Six months later, the deal closed.
With multi-touch attribution, you can attribute a share of that £250,000 to each of those touchpoints: organic search, the LinkedIn ad, the webinar, the email campaign, the content download, and the congress interaction. The specific share depends on which attribution model you use (first touch, linear, W-shaped, and so on), but the point is that you can now see how each marketing activity contributed to actual revenue, not just leads.
Without a CRM connecting all of this, your LinkedIn Campaign Manager would show one webinar registration. Your email platform would show one PDF download. GA4 would show two website visits from different people. And none of them would know about the congress meeting or the £250,000 deal that resulted. That's the difference between platform-level metrics and true revenue attribution.
Despite the clear benefits of end-to-end revenue attribution, many medical device companies still don't use a CRM, or they have one that's poorly adopted. The reasons we hear most often are the complexity of setup, the cost, the time required to get it running properly, and a fear that the sales team won't use it.
These concerns aren't unfounded. Setting up a CRM properly does take time and effort. You need to configure your deal pipeline stages, set up lead scoring, create the right properties and custom fields, integrate your marketing tools, train your team, and build the reports and dashboards that will actually drive decisions. For a small medical device company without a dedicated marketing operations person, this can feel overwhelming.
And poor CRM adoption is a real and common problem. If your sales team views the CRM as an administrative burden rather than a useful tool, they won't log their activities consistently, and your data will be incomplete. Incomplete data means inaccurate attribution, which means the whole system loses its value. We've seen this happen often enough to take the concern seriously.
However, the alternative, continuing to measure marketing performance through disconnected platform dashboards and manual spreadsheets, has a cost too. It's just less visible. Every month that you can't connect your marketing spend to revenue, you're making budget decisions based on incomplete information. You're potentially wasting money on campaigns that look good in one platform's dashboard but don't actually contribute to sales. And you're missing the opportunity to double down on the activities that are genuinely driving revenue.
In our experience, the companies that succeed with CRM adoption are the ones that invest in proper setup from the beginning (either in-house or with a partner), get buy-in from both marketing and sales leadership before they start, and choose a platform that matches their team's technical capability. A simpler CRM that your team actually uses will always deliver more value than a powerful one that gathers dust. If CRM selection is something you're working through, our article on which CRM is right for your medical device company covers the main options in detail.
The right approach to measuring marketing ROI depends on where you are as a company, what resources you have, and how complex your sales cycle is. Here's a practical framework for thinking about it.
If you're an early-stage company with a small marketing team and a limited budget, start with the basics. Get GA4, Google Search Console, and Google Tag Manager set up properly. Use GTM to track the key actions on your website (form submissions, content downloads, demo requests) so your GA4 data actually reflects what's happening. Use UTM codes consistently on every link. Use whatever analytics your individual platforms provide. This won't give you revenue attribution, but it will give you a baseline understanding of which channels are driving activity. This is a perfectly valid starting point, and it's far better than measuring nothing.
If you're generating a steady volume of leads and your sales team is actively working a pipeline, it's time to invest in a CRM. The cost of not having one grows with every deal that closes without you knowing which marketing activities contributed to it. At this stage, the choice of platform matters: HubSpot tends to be a strong fit for small to mid-sized companies that want marketing and sales tools in one place without needing a dedicated administrator. Salesforce is better suited to larger organisations with more complex requirements and the technical resources to manage it. Dynamics 365 makes sense if your company is already deeply invested in the Microsoft ecosystem.
If you're a larger medical device company with multiple product lines and a national or global sales team, you'll likely need a CRM combined with a commercial intelligence platform like AcuityMD, a BI tool like Tableau or Power BI, or both. At this level, the focus shifts from basic attribution to sophisticated multi-touch modelling, pipeline velocity analysis, and territory-level ROI measurement.
Whatever stage you're at, the most important thing is to start. Perfect measurement doesn't exist, especially in an industry with the complexity of medical devices. But even imperfect measurement that connects some of your marketing activity to revenue is dramatically more useful than reporting on clicks and impressions in isolation.
Measuring medical device marketing ROI is difficult, but it isn't impossible. The key is understanding the limitations of each approach and building towards a system that connects your marketing activity to real revenue.
Individual platform analytics, such as GA4, Google Search Console, Google Tag Manager, LinkedIn Campaign Manager, Google Ads, and your email platform, are essential starting points. They tell you how each channel is performing in isolation, and GTM ensures you're actually capturing the website actions that matter. UTM codes help you connect campaign activity to website analytics. But on their own, these platforms can't tell you which campaigns actually contributed to closed deals.
The spreadsheet collation approach is better than nothing, but it's manual, time-consuming, and still doesn't solve the revenue attribution problem. To truly measure marketing ROI, you need an end-to-end system that tracks the journey from first touch to closed deal, and that means investing in a CRM.
HubSpot, Salesforce, Microsoft Dynamics 365, and commercial intelligence platforms like AcuityMD all offer different approaches to solving this challenge. The right choice depends on your company's size, technical resources, existing tech stack, and the complexity of your sales cycle. The CRM setup process can feel daunting, and adoption challenges are real, but the cost of not being able to connect your marketing spend to revenue is almost always higher.
If you're not sure where to start, or if you're looking for help setting up a CRM and building the attribution reports that will let you measure marketing ROI properly, book a free strategy call and we'll talk you through your options.